Inhibition of EZH2 by chemo- and radiotherapy agents and small molecule inhibitors induces cell death in castration-resistant prostate cancer

Androgen deprivation therapy is the mainstay of treatment of advanced prostate cancer (PCa). However, a significant portion of patients experience disease relapse and tumors ultimately evolve into castration resistant prostate cancer (CRPC), for which there is no cure in the clinic. The Polycomb pro...

Full description

Bibliographic Details

Main Authors:	Wu, Changping, Jin, Xin, Yang, Jing, Yang, Yinhui, He, Yundong, Ding, Liya, Pan, Yunqian, Chen, Shuai, Jiang, Jingting, Huang, Haojie
Format:	Online
Language:	English
Published:	Impact Journals LLC 2015
Subjects:	Research Paper
Online Access:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4823118/
Tags:	Add Tag No Tags, Be the first to tag this record!